# Inbrija

NDC: 10144-342
Generic name: levodopa
Labeler / Manufacturer: Merz Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: RESPIRATORY (INHALATION)
Marketing started: 20181222

FDA application: NDA209184

## Active ingredients

- LEVODOPA: 42 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10144-342"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10144-342
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a906f8e1-6e1c-480a-8276-c01bc65dd3be